Ian P Wicks Selected Research

Ian P Wicks Research Topics

Disease

30	Inflammation (Inflammations) 01/2023 - 08/2004
23	Arthritis (Polyarthritis) 01/2023 - 03/2003
22	Rheumatoid Arthritis 01/2022 - 10/2003
8	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 10/2005
8	Experimental Arthritis 01/2019 - 08/2004
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 03/2015
4	Atherosclerosis 01/2023 - 08/2011
4	Neoplasms (Cancer) 01/2022 - 01/2015
4	Infections 01/2021 - 09/2011
3	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2023 - 01/2016
3	Rheumatic Diseases (Rheumatism) 12/2020 - 01/2017
2	Multiple Sclerosis 01/2022 - 01/2020
2	Communicable Diseases (Infectious Diseases) 01/2021 - 08/2015
2	Melanoma (Melanoma, Malignant) 01/2021 - 12/2018
2	Myocardial Infarction 01/2020 - 01/2010
2	Gout 01/2019 - 01/2018
2	Myocarditis (Carditis) 01/2019 - 12/2018
2	Vasculitis (Vasculitides) 01/2019 - 01/2019
2	Lymphopenia (Lymphocytopenia) 01/2017 - 10/2011
2	Joint Diseases (Joint Disease) 12/2016 - 08/2004
2	Necrosis 01/2015 - 10/2003
1	Fibrosis (Cirrhosis) 01/2023
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2023
1	Hyperplasia 01/2023
1	Polymyositis 10/2022
1	Muscle Weakness 10/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Colitis 01/2022
1	Periodontitis 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Celiac Disease (Celiac Sprue) 12/2021
1	COVID-19 01/2021
1	Disease Progression 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Rupture 01/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Bites and Stings (Sting) 01/2020
1	Rheumatic Heart Disease (Rheumatic Heart Diseases) 12/2018
1	Rheumatic Fever (Acute Articular Rheumatism) 12/2018

Drug/Important Bio-Agent (IBA)

23	CytokinesIBA 01/2023 - 03/2003
12	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 12/2005
9	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 08/2004
6	Interleukin-6 (Interleukin 6)IBA 05/2021 - 05/2003
6	AutoantibodiesIBA 01/2020 - 10/2005
5	Interleukin-1 (Interleukin 1)IBA 01/2020 - 01/2005
5	methylated bovine serum albumin (MBSA)IBA 04/2013 - 01/2005
4	ChemokinesIBA 01/2023 - 01/2016
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023 - 12/2018
4	AntibodiesIBA 10/2022 - 10/2005
4	Biomarkers (Surrogate Marker)IBA 12/2020 - 05/2011
4	Interleukin-17 (Interleukin 17)IBA 06/2015 - 12/2008
3	CholesterolIBA 01/2023 - 01/2018
3	AntigensIBA 12/2021 - 01/2006
3	InterferonsIBA 01/2020 - 03/2015
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2003
2	Interleukin-11 (Interleukin 11)IBA 01/2022 - 01/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021 - 09/2006
2	RNA (Ribonucleic Acid)IBA 05/2021 - 10/2019
2	Antirheumatic Agents (DMARD)IBA 12/2020 - 03/2006
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2019
2	LigandsIBA 01/2019 - 06/2015
2	Uric Acid (Urate)IBA 01/2019 - 01/2018
2	Retinaldehyde (Retinal)IBA 02/2016 - 05/2011
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2013 - 10/2005
2	Collagen Type II (Type II Collagen)IBA 06/2009 - 10/2005
2	Messenger RNA (mRNA)IBA 12/2008 - 11/2002
2	Peptide Hydrolases (Proteases)FDA Link 08/2008 - 09/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006 - 08/2004
1	Chloroquine (Aralen)FDA LinkGeneric 01/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	Antimalarials (Antimalarial Agents)IBA 01/2023
1	LipidsIBA 01/2023
1	Liver X ReceptorsIBA 01/2023
1	T0901317IBA 01/2023
1	Granzymes (Granzyme)IBA 10/2022
1	Fas Ligand Protein (Fas Ligand)IBA 10/2022
1	PerforinIBA 10/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2021
1	MicroRNAs (MicroRNA)IBA 05/2021
1	Small Untranslated RNAIBA 12/2020
1	IntegrinsIBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	Interferon Type IIBA 01/2020
1	TetraspaninsIBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	L-SelectinIBA 01/2020
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	cytokine inducible SH2-containing proteinIBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	Therapeutic UsesIBA 01/2019
1	Interleukin-3 (Interleukin 3)IBA 01/2019

Therapy/Procedure

12	Therapeutics 01/2023 - 10/2003
2	Injections 09/2014 - 01/2005
1	Immunomodulation 01/2023
1	Immunotherapy 01/2021